Pharmafile Logo

Sir Bruce Keogh is appointed chair of judges for HSJ Awards

Sir Bruce Keogh, the former National Medical Director for NHS England, will chair the judges’ panel for the 37th annual HSJ Awards – the world’s largest healthcare awards programme.

Sir Bruce Keogh is appointed chair of judges for HSJ Awards

Sir Bruce Keogh, the former National Medical Director for NHS England, will chair the judges’ panel for the 37th annual HSJ Awards – the world’s largest healthcare awards programme.
In this newly created role of chair, Sir Bruce will lead around 180 judges who will scrutinize entries for the awards, which recognise healthcare professionals and institutions that continue to innovate and improve services for patients. Sir Bruce’s responsibilities will include recruiting new judges and reviewing judges’ scores and commentary. He will also ensure that the process for the awards scheme, which includes eight new categories, and will provide individual feedback on each entry this year for the first time, remains fair and transparent.

Sir Bruce who is chair of Birmingham Women’s and Children’s NHS Foundation Trust, said: “I feel honoured to have been asked to chair the judges’ panel on this prestigious awards scheme, which highlights some of the very best ideas, people and organisations in our NHS.
  “On the human side, recognising excellence and innovation, publicly or privately, makes those responsible, feel warm and valued and encourages them to go further. On a more practical side, well publicised awards raise the profile and reflect well on individuals and organisations, making others want to emulate the winners. These awards help spread the word.”  

HSJ Editor, Alastair McLellan, said: Sir Bruce is one of the most respected figures in the NHS. As the first medical director of, initially, the Department of Health and then NHS England he was in the vanguard of national initiatives to drive up healthcare quality during a period of very significant challenge for NHS. We are very pleased and proud he will become our first chair of judges.”
 

Andrew Preston, Chief Executive, de Poel health+care, which sponsors the awards, said: “Celebrating the success stories of our partners in healthcare is the reason for supporting the HSJ Awards. I am delighted that Sir Bruce has joined as Chair of Judges, as his wealth of experience and reputation across the NHS will serve to further highlight the great work that the HSJ Awards entrants do for patient care.”

Entries for the HSJ Awards are welcomed from healthcare professionals wishing to share best practice, teams looking for recognition for exceptional work, organisations celebrating improvements in patient outcomes and private organisations wanting to showcase their partnerships. 

Many of the most popular award categories from previous years have returned, including the chief executive and the provider trust of the year. The eight new awards include acute or specialist services redesign, patient digital participation, creating a supportive staff culture and optimisation of medicines management.

The closing deadline for all submissions is 31 May and the presentation ceremony will take place on 21 November 2018. For further information on the awards and how to enter, log on to https://awards.hsj.co.uk.
 

- PMLiVE

ENDS  

For more information:
Andrew Baud, Tala, 020 3397 3383 or 07775 715775, andrew.baud@teamtala.com  

Note to Editors:
About HSJ HSJ is the only title to cover all aspects of publicly funded healthcare, providing news, analysis, best practice information and advice from the most powerful people in health, for the most powerful people in health. The HSJ audience is formed of healthcare leaders from both clinical and non-clinical backgrounds and both public and private sectors. To find out more about HSJ click here.

About Wilmington plc

Wilmington plc is a dynamic and expanding company with a common aim – turning knowledge into advantage.
Wilmington plc provides information and training to professional business markets within the Risk and Compliance, Finance, Legal and Insight sectors. Wilmington plc enables professionals and their organisations to enhance performance by providing high quality, relevant and reliable information, education and knowledge. Wilmington plc are underpinned by the core values of enhancing, enabling, collaborating and innovating. To find out more about Wilmington plc click here.

This content was provided by Wilmington Healthcare

Company Details

 Latest Content from  Wilmington Healthcare 

Considering a portfolio review?

Are you considering a portfolio review for your established pharmaceutical brands? Wondering if you should put some activity behind them? At CHASE our experienced team will ensure you maximise your...

UNDERSTANDING THE ROLE OF PLACE WITHIN THE NEW NHS: FIVE THINGS INDUSTRY NEEDS TO KNOW

Operating a level below system, “place” is an increasingly important unit of NHS organisation, yet it remains an evolving concept that is not always well-understood among industry practitioners. In this...

MISSION CRITICAL: HOW PHARMA CAN HELP THE NHS IMPROVE CARE FOR OLDER PEOPLE

With around two-thirds of all hospital beds occupied by over-65s, the care of older patients has long been recognised as key to the sustainability of the NHS. So how is...

ALL CHANGE FOR SPECIALISED COMMISSIONING: FOUR THINGS INDUSTRY NEEDS TO KNOW ABOUT THE LATEST REFORMS

With a recent NHSEI policy document confirming that a major shake-up of arrangements for Specialised Commissioning is imminent, Oli Hudson, Content Director at Wilmington Healthcare (wilmingtonhealthcare.com), describes the key changes...

HOW DID COVID-19 AFFECT PRESCRIBING BEHAVIOURS? FIVE KEY FINDINGS FROM A NEW STATE OF THE NATION REVIEW

Published earlier this month, Wilmington Healthcare’s new State of the Nation report draws on a raft of data from across primary and secondary care to show what actually happened to...

ALL SYSTEMS GO: UNDERSTANDING WHO’S WHO IN THE NEW NHS LANDSCAPE

With the Health and Care Act safely passed, Oli Hudson introduces six key stakeholders that will loom large in the new landscape.

Spending on anti-depressants soars as the pandemic’s effect on NHS prescribing patterns is revealed

Wilmington Healthcare’s State of the Nation prescribing report shows that spending on sertraline, commonly used to treat depression and anxiety, increased by 305.5% between 2019/20 and 2020/21 while overall spend...

EQUAL FOOTING: HOW PHARMA CAN HELP THE NHS TO ACT ON HEALTH INEQUALITIES

As the NHS puts a renewed focus on reducing health inequalities, Oli Hudson looks at what opportunities this might it bring for Industry and how it can best play its...

UNDERSTANDING THE NEW VALUE PROPOSITION FOR THE NHS

Industry needs a new way of describing its commercial propositions in response to the changing NHS landscape, argues Wilmington Healthcare’s Oli Hudson. This ‘new value proposition’ needs to be reflected...